Tumor infiltrating lymphocyte (TIL) density was higher in DCIS lesions with TP53 mutations (p=0.0079) compared to wildtype lesions, but not in lesions with <i>PIK3CA</i> mutations (p=0.44). Here, PIK3CA is linked to ductal breast carcinoma in situ.